Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 March 2008, Vol. 111, No. 6, pp. 3050-3061.
Prepublished online as a Blood First Edition Paper on January 7, 2008; DOI 10.1182/blood-2007-11-122408.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-11-122408v1
111/6/3050    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Escors, D.
Right arrow Articles by Collins, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Escors, D.
Right arrow Articles by Collins, M. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted November 7, 2007
Accepted December 6, 2007

Targeting dendritic cell signalling to regulate the response to immunisation

David Escors, Luciene Lopes, Rongtuan Lin, John Hiscott, Shizuo Akira, Roger J. Davis, and Mary K. Collins*

Infection and Immunity, University College London, London, United Kingdom
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada
Department of Host Defence, Rsearch Institute for Microbial Diseases, Osaka University, Osaka, Japan
Howard Hughes Medical Institute and Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, United States

* Corresponding author; email: mary.collins{at}ucl.ac.uk.

Dendritic cells (DC) are key regulators of the immune system; they capture antigens and then can either stimulate an immune response or induce tolerance. Our aim was to activate individual DC signaling pathways to regulate the immune response. We therefore expressed constitutive activators of mitogen-activated protein kinase (MAPK) pathways or the interferon pathway, together with tumor antigens, using lentivectors. Triggering of p38 activated DC, substantially enhanced the anti-tumor immune response and prolonged survival of tumor-bearing mice. Activation of ERK increased TGF-{beta} expression while expression of a constitutively activated interferon regulatory factor-3 (IRF3) stimulated IL-10 secretion by DC. ERK and IRF3 suppressed the immune response and stimulated expansion of regulatory T cells. These results provide a toolkit to regulate immune responses to viral vector or DC immunization; vaccine responses to foreign or tumor antigens can be enhanced and harmful responses to self-antigens or introduced transgenes can be reduced.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
R. van de Ven, R. Oerlemans, J. W. van der Heijden, G. L. Scheffer, T. D. de Gruijl, G. Jansen, and R. J. Scheper
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer
J. Leukoc. Biol., November 1, 2009; 86(5): 1075 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Zhao, C. Falk, W. Osen, M. Kato, D. Schadendorf, and V. Umansky
Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma
Clin. Cancer Res., July 1, 2009; 15(13): 4382 - 4390.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Karwacz, S. Mukherjee, L. Apolonia, M. P. Blundell, G. Bouma, D. Escors, M. K. Collins, and A. J. Thrasher
Nonintegrating Lentivector Vaccines Stimulate Prolonged T-Cell and Antibody Responses and Are Effective in Tumor Therapy
J. Virol., April 1, 2009; 83(7): 3094 - 3103.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. M. Rowe, L. Lopes, N. Brown, S. Efklidou, T. Smallie, S. Karrar, P. M. Kaye, and M. K. Collins
Expression of vFLIP in a Lentiviral Vaccine Vector Activates NF-{kappa}B, Matures Dendritic Cells, and Increases CD8+ T-Cell Responses
J. Virol., February 15, 2009; 83(4): 1555 - 1562.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-B. Sun, C.-F. Flach, C. Czerkinsky, and J. Holmgren
B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit
J. Immunol., December 15, 2008; 181(12): 8278 - 8287.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020